alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>


<ARTICLE> 5
<LEGEND>
This  schedule  contains  summary  financial   information  extracted  from  the
Registrant's  unaudited  interim  financial  statements for the six month period
ended June 30,  2000 and is  qualified  in its  entirety by  reference  to those
financial statements.
</LEGEND> <CIK> 0000895993
<NAME> RIDGEWOOD ELECTRIC POWER TRUST II
         <S>                             <C>
<PERIOD-TYPE>                                    6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                         142,708
<SECURITIES>                                10,425,092<F1>
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               145,640<F2>
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              12,081,430
<CURRENT-LIABILITIES>                           14,812
<BONDS>                                              0
<COMMON>                                             0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                  12,066,618<F3>
<TOTAL-LIABILITY-AND-EQUITY>                12,081,430
<SALES>                                              0
<TOTAL-REVENUES>                               409,235
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                45,767
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                363,468
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            363,468
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   363,468
<EPS-BASIC>                                      1,544
<EPS-DILUTED>                                    1,544

<FN>
<F1>Investments in power project partnerships.
<F2>Includes $2,361 due from affiliates
<F3>Represents Investor Shares of beneficial interest
in Trust with capital accounts of $12,137,376 less
managing shareholder's accumulated deficit of $80,577.
</FN>


</TABLE>
<PAGE>
                                                                   EXHIBIT 10.26

                  Summary of the Director Compensation Program


         Penwest Pharmaceuticals Co. ("the Company") maintains a director
compensation program for its directors that is administered by the Compensation
Committee of the Board of Directors of the Company. Under this program:

     -   Each of the Company's non-employee directors receives an annual
         retainer of $20,000 per year, payable in quarterly installments on the
         first business day of each calendar quarter. Each non-employee director
         may elect to receive this annual retainer in cash, shares of the
         Company's common stock, or both.

     -   Each non-employee director also receives, in cash or shares of the
         Company's common stock pursuant to the director's elections, fees of
         $1,500 for each board meeting attended in person and fees of between
         $500 and $1,000 for each board meeting attended telephonically.

     -   All non-employee directors receive reimbursement for all reasonable
         expenses incurred in attending meetings of the Board and committees of
         the Board.

     -   On the first business day of each calendar year, the Company issues to
         each non-employee director either options to purchase 12,000 shares of
         the Company's common stock or a grant of 6,000 shares of restricted
         common stock, as elected by the director. The exercise price of these
         options equals the fair market value of one share of the Company's
         common stock on the date of grant. Options granted pursuant to the
         director compensation program vest on the first anniversary of the date
         of grant. Restricted common stock granted pursuant to the director
         compensation program is granted without requiring payment of additional
         consideration by the director and vests on the first anniversary of the
         grant date. The vesting of options and of the restricted common stock
         is subject to acceleration in full upon the occurrence of a change in
         control of the Company.

     -   Upon the date of the initial election of any non-employee director to
         the Board, the Company grants such non-employee director 20,000 shares
         of restricted common stock and grants an additional 12,000 shares of
         restricted common stock generally every four years thereafter. These
         shares vest in four equal annual installments commencing upon the first
         anniversary of the date of grant. The vesting of the restricted common
         stock is subject to acceleration in full upon the occurrence of a
         change in control of the Company.
### §1010. Suspension of operations and production

The Secretary, upon application by the lessee, may authorize the lessee to suspend operations and production on a producing lease and he may, on his own motion, in the interest of conservation suspend operations on any lease but in either case he may extend the lease term for the period of any suspension, and he may waive, suspend, or reduce the rental or royalty required in such lease.

(Pub. L. 91–581, §11, Dec. 24, 1970, 84 Stat. 1570; Pub. L. 109–58, title II, §236(11), Aug. 8, 2005, 119 Stat. 672.)

#### **Editorial Notes**

#### Amendments

2005—Pub. L. 109–58 inserted section catchline.
### §3062. Relative rank of officers when serving with Army, Navy, or Air Force

When serving with the Army, Navy, or Air Force, an officer of the Administration shall rank with and after officers of corresponding grade in the Army, Navy, or Air Force of the same length of service in grade. Nothing in this subchapter shall be construed to affect or alter an officer's rates of pay and allowances when not assigned to military duty.

(Pub. L. 107–372, title II, §252, Dec. 19, 2002, 116 Stat. 3091.)

#### **Editorial Notes**

#### Prior Provisions

Provisions similar to those in this section were contained in section 856 of this title prior to repeal by Pub. L. 107–372.
[Federal Register Volume 69, Number 207 (Wednesday, October 27, 2004)]
[Notices]
[Page 62707]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-24024]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, National Center for Infectious 
Disease

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting.

    Name: Board of Scientific Counselors, National Center for 
Infectious Diseases (NCID).
    Times and Dates: 9 a.m.--5:30 p.m., December 9, 2004. 8:30 a.m.-
2 p.m., December 10, 2004.
    Place: CDC, Auditorium B, Building 1, 1600 Clifton Road, 
Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The Board of Scientific Counselors, NCID, provides 
advice and guidance to the Director, CDC, and Director, NCID, in the 
following areas: program goals and objectives; strategies; program 
organization and resources for infectious disease prevention and 
control; and program priorities.
    Matters To Be Discussed: Agenda items will include:
1. Opening Session: NCID Update
2. Futures Initiative Update
3. Environmental Microbiology
4. IT Consolidations/Bioinformatics Center
5. Veterinary-Human Public Health Interface
6. Global Disease Detection Initiative
7. Topic Updates
    a. Influenza
    b. Pneumococcal Disease
    c. Genetics Initiatives
8. Board meets with Director, CDC
    Other agenda items include announcements/introductions; follow-up 
on actions recommended by the Board May 2004; consideration of future 
directions, goals, and recommendations.
    Agenda items are subject to change as priorities dictate.
    Written comments are welcome and should be received by the contact 
person listed below prior to the opening of the meeting.
    For Further Information Contact: Tony Johnson, Office of the 
Director, NCID, CDC, Mailstop E-51, 1600 Clifton Road, NEO, Atlanta, 
Georgia 30333, e-mail <a href="/cdn-cgi/l/email-protection#295d434641475a46471a694a4d4a074e465f"><span class="__cf_email__" data-cfemail="e5918f8a8d8b968a8bd6a5868186cb828a93">[email protected]</span></a>; telephone 404/498-3249.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.


    Dated: October 20, 2004.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 04-24024 Filed 10-26-04; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
§ 1303.50 Responses to requests. ( a ) *Acknowledgments of requests.* OMB will assign an individualized tracking number to each request received that will take longer than ten days to process; and acknowledge each request, informing the requester of their tracking number if applicable; and, upon request, make available information about the status of a request to the requester using the assigned tracking number, including— ( 1 ) The date on which OMB originally received the request; and
( 2 ) An estimated date on which OMB will complete action on the request.
( b ) *Grants of requests.* Once OMB makes a determination to grant a request in full or in part, it will notify the requester in writing. OMB also will inform the requester of any fees charged under § 1303.9 and shall provide the requested records to the requester promptly upon payment of any applicable fees. OMB will inform the requester of the availability of the FOIA Public Liaison to offer assistance.
( c ) *Adverse determinations of requests.* Adverse determinations, or denials of requests, include decisions that the requested record is exempt, in whole or in part; the request does not reasonably describe the records sought; the information requested is not a record subject to the FOIA; the requested record does not exist, cannot be located, or has been destroyed; or the requested record is not readily reproducible in the form or format sought by the requester. Adverse determinations also include denials involving fees or fee waiver matters or denials of requests for expedited processing. In the case of an adverse determination, the FOIA Officer will immediately notify the requester of— ( 1 ) The right of the requester to appeal to the head of OMB within 90 calendar days after the date of such adverse determination in accordance with § 1303.70;
( 2 ) The right of such person to seek dispute resolution services from the FOIA Public Liaison or the OGIS at NARA;
( 3 ) The names and titles or positions of each person responsible for the denial of such request; and
( 4 ) OMB's estimate of the volume of any requested records OMB is withholding, unless providing such estimate would harm an interest protected by the exemption in 5 U.S.C. 552(b) under which the withholding is being made.
[84 FR 22951, May 21, 2019, as amended at 89 FR 48825, June 10, 2024]
#### § 1204.1 Purpose.

This part implements the Freedom of Information Act (FOIA), 5 U.S.C. 552, as amended, by stating the procedures to follow when requesting information from the Board, and by stating the fees that will be charged for that information.
NRC NEWS

UNITED STATES NUCLEAR REGULATORY COMMISSION

OFFICE OF PUBLIC AFFAIRS, REGION II

61 Forsyth Street SW, Atlanta GA 30303

Web Site: www.nrc.gov

No. II-06-001 February 2, 2006

CONTACT: Ken Clark (404)562-4416 E-mail: OPA2@nrc.gov

Roger Hannah (404)562-4417

NRC SCHEDULES MEETING WITH DUKE ENERGY TO DISCUSS

INSPECTION FINDING AT OCONEE NUCLEAR POWER PLANT

The Nuclear Regulatory Commission staff has scheduled a meeting with Duke Energy officials

on Monday, Feb. 6 to discuss the risk significance of an NRC inspection finding at the company’s

Oconee nuclear plant near Seneca, S.C. 

The inspection finding involved a failure to promptly identify and correct a discrepancy

between the Oconee Unit 3 control room’s exterior wall as it is constructed and the way it is described

in the plant’s licensing documents. This particular discrepancy relates to the control room’s ability to

withstand damage from a tornado, and has been preliminarily designated by the NRC staff as “greater

than green” (having more than very low safety significance). 

The meeting is scheduled for 10:00 a.m. in the NRC’s Region II office, located on the 24th floor

of the Atlanta Federal Center at 61 Forsyth Street SW in Atlanta. The public is invited to attend to

observe and will have one or more opportunities to communicate with the NRC after the business

portion, but before the meeting is adjourned.

No decisions on the final safety significance, apparent violations or possible enforcement action

will be made during the conference. Those decisions will be made by NRC officials at a later time.

###
[Federal Register Volume 69, Number 212 (Wednesday, November 3, 2004)]
[Notices]
[Page 64034]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-24512]


=======================================================================
-----------------------------------------------------------------------

COMMISSION OF FINE ARTS


Notice of Meeting

    The next meeting of the Commission of Fine Arts is scheduled for 18 
November 2004 at 10 a.m. in the Commission's offices at the National 
Building Museum, Suite 312, Judiciary Square, 401 F Street, NW., 
Washington, DC 20001-2728. Items of discussion affecting the appearance 
of Washington, DC, may include buildings, parks and memorials.
    Draft agendas and additional information regarding the Commission 
are available on our Web Site http://www.cfa.gov. Inquiries regarding 
the agenda and requests to submit written or oral statements should be 
addressed to Frederick J. Lindstrom, Acting Secretary, Commission of 
Fine Arts, at the above address or call 202-504-2200. Individuals 
requiring sign language interpretation for the hearing impaired should 
contact the Secretary at least 10 days before the meeting date.

    Dated in Washington, DC, 27 October 2004.
Frederick J. Lindstrom,
Acting Secretary.
[FR Doc. 04-24512 Filed 11-2-04; 8:45 am]
BILLING CODE 6330-01-M
Exhibit 32.2



Written Statement of Chief Financial Officer

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002



The undersigned, the Chief Financial Officer of Central European Distribution Corporation (the Company), hereby certifies that, to his
knowledge on the date hereof:



| | (a) | the Form 10-K of the Company for the fiscal year ended December 31, 2004, filed on the date hereof with the Securities and Exchange Commission (the Report) fully
complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | (b) | information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ------------------------------------------------------------------------------------------------------------------------------------------------



Dated: March 15, 2005



By:

/s/ Chris BiedermannChris BiedermannChief Financial Officer
NRC NEWS

U.S. NUCLEAR REGULATORY COMMISSION

Office of Public Affairs Telephone: 301/415-8200

Washington, DC 20555-001 E-mail: opa@nrc.gov

Web Site: http://www.nrc.gov/OPA

No. 00-098 June 16, 2000

NRC TO REVIEW INCIDENT

AT UNIVERSITY OF MISSOURI RESEARCH REACTOR

The Nuclear Regulatory Commission (NRC) is reviewing the circumstances surrounding a

second incident in recent months at the University of Missouri nuclear non-power research reactor in

Columbia.

A supervisor and two inspectors from the agency’s headquarters in Rockville, Maryland, on site

for a previously scheduled inspection, will review an incident this week that involved the removal of a

control rod from the shutdown reactor apparently without following the required procedures. The rod

is used to control the reactor’s power.

The NRC was notified of the incident by officials of the University of Missouri, the licensee of

the facility. The reactor remained shut down for a period to enable the university to evaluate the

incident.

Conference calls between NRC officials and licensee management were held June 13 and 14 to

discuss the apparent root cause of the incident, the corrective actions taken and the licensee’s decision

process for restarting the reactor, which took place on June 15.

A similar maintenance procedural incident occurred at the reactor two months earlier. The

licensee has indicated that there were no adverse effects from that event. The licensee is still

evaluating this week’s incident. The NRC staff’s evaluation of long-term corrective actions for both

events continues.

Non-power reactors, whose function is research and development, are used in almost every field

of science, including physics, chemistry, biology, medicine, geology, archeology and environmental

sciences.

##
Home > NRC Library > ADAMS Public Documents

# SECY-06-0139 - Secure Transfer of Nuclear Material (RIN:  3150-AH90)

Accession Number: ML060390265

Date Released: Wednesday, July 5, 2006

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.
    - ML061360304 - SECY-06-0139 - Secure Transfer of Nuclear Material (RIN: 3150-AH90) (9 page(s), 6/20/2006)
    - ML061360310 - SECY-06-0139 - Enclosure:  Federal Register Notice for Proposed Rule:  Secure Transfer of Nuclear Materials (21 page(s), 6/20/2006)

Privacy PolicySite Disclaimer
NRC NEWS

UNITED STATES NUCLEAR REGULATORY COMMISSION

OFFICE OF PUBLIC AFFAIRS, REGION II

61 Forsyth Street SW, Atlanta GA 30303

Web Site: www.nrc.gov

No. II-05-012 March 23, 2005

CONTACT: Ken Clark (404)562-4416 E-mail: OPA2@nrc.gov

Roger Hannah (404)562-4417

NRC TO DISCUSS 2004 PERFORMANCE AT SURRY NUCLEAR POWER PLANT

The Nuclear Regulatory Commission staff will meet with Virginia Electric and Power

Company officials on March 30 to discuss the NRC’s annual assessment of safety performance at the

Surry nuclear power plant, located near Surry, Va. The period covered is the calendar year 2004.

The meeting will begin at 2:00 p.m. (EST) at the Surry Government Center, located at 45

School Street in Surry. It is open to public observation. Before the end of the meeting, the NRC staff

will be available to answer questions from interested observers related to the plant’s safety

performance, as well as the NRC’s role in ensuring safe operation of the facility.

Dr. William Travers, Administrator of the NRC’s Region II office in Atlanta, said “the NRC

staff rates the performance of each of the nation’s licensed, commercial nuclear power plants each

year.” He said the public meeting with the company “gives the NRC a chance to discuss the

assessment with company and local officials and interested residents living near the plant.” He said

NRC officials will answer any questions people may have related to the agency’s oversight of safety

and operations at Surry.

A letter sent from the NRC Region II office in Atlanta to plant officials addresses the plant’s

performance during 2004 and will serve as the basis for the meeting discussion. It is available on the

NRC web site at www.nrc.gov/NRR/OVERSIGHT/ASSESS/LETTERS/sur_2004q4.pdf .

The NRC uses color coded inspection findings and performance indicators to assess nuclear

power plant performance. The colors start with “green” and increase to “white,” “yellow,” or “red,”

commensurate with the safety significance of the issues involved. 

Surry Units 1 and 2 operated safely during 2004, the NRC report said. One inspection finding

and one Performance Indicator, both designated as “white,” (of low to moderate safety significance),

occurred during the review period. A subsequent NRC inspection found that the company’s corrective

actions were adequate to address the issues. Based on these results and overall performance, the NRC

will conduct only normal reactor oversight safety inspections during the next evaluation period. 

Routine Inspections are performed by NRC Resident Inspectors assigned to the plant and by

inspection specialists from the Region II office in Atlanta and the agency’s headquarters in Rockville,

Md. In addition to the baseline inspections in 2005, the NRC plans inspections of Surry’s Independent

Spent Fuel (Dry Cask) Storage Installation.
Current information for the Surry plant is available on the NRC web site at:

www.nrc.gov/NRR/OVERSIGHT/ASSESS/SUR1/sur1_chart.html and

www.nrc.gov/NRR/OVERSIGHT/ASSESS/SUR2/sur2_chart.html .

###
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Nuclear Regulatory Commission

# FOR FURTHER INFORMATION CONTACT:

Mr. Richard K. Major (telephone: 301-415-7366) or Dr. Richard P. Savio (telephone: 301-415-7362) between 7:30 a.m. and 4:15 p.m. (e.t.). 

Dated: October 19, 2004. 

John H. Flack, 

Acting Branch Chief, ACRS/ACNW. 

[FR Doc. 04-23902 Filed 10-25-04; 8:45 am] 

BILLING CODE 7590-01-P